An official website of the United States government
Here's how you know
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.
Brought to you by the Council of the Inspectors General on Integrity and Efficiency
Federal Reports
Report Date
Agency Reviewed / Investigated
Report Title
Type
Location
Department of Veterans Affairs
Evaluation of Specimen Readings for Accuracy and Quality Assurance in the Laboratory at the John D. Dingell VA Medical Center in Detroit, Michigan
The VA Office of Inspector General (OIG) conducted a healthcare inspection at the John D. Dingell VA Medical Center (facility) to evaluate allegations of inaccurate complete blood count (CBC) with differential results and reporting, and a laboratory supervisor not passing a proficiency test. The OIG identified concerns regarding quality assurance processes and laboratory leaders’ response, which were not in compliance with VHA Directive 1106, Pathology and Laboratory Medicine Service and VHA Directive 1050.01(1), VHA Quality and Patient Safety Programs.
The OIG substantiated eight medical technologists (technologists) missed or under reported blast cells, leading to inaccurate CBC with differential results for a patient. The OIG did not identify adverse clinical outcomes.
Laboratory leaders did not implement a quality assurance process to ensure the accuracy of CBC with differential results. Further, none of the technologists were informed of the inaccurate readings, precluding mitigation of errors. Pathologists completed the OIG-requested retrospective review of readings, but the OIG remains concerned that misreads may continue without sustained oversight.
Laboratory leaders, including the quality management technologist, and patient safety managers, did not ensure corrective actions were timely implemented or tracked. Factors contributing to delayed completion of corrective actions and unresolved patient safety risks included conflicting interpretations of the quality management technologist’s responsibilities and laboratory leaders not following a reporting policy.
The OIG substantiated a supervisor did not pass a blood bank proficiency test in summer 2024, leading to the suspension of blood bank crossmatch testing services. However, laboratory leaders constructed a contingency plan and completed requirements to resume services within a week.
The Facility Director concurred with the OIG’s five recommendations related to communicating errors to technologists, patient safety staff’s monitoring of action plans, clarification of the quality management technologist’s role, oversight of accuracy for CBC results, and laboratory leaders not following a reporting policy.
Audit of the National Association of Letter Carriers Health Benefit Plan’s Pharmacy Operations as Administered by CVS Caremark for Contract Years 2018 Through 2023
Independent Performance Audit on the Effectiveness of the U.S. General Services Administration’s Information Security Program and Practices Report - Fiscal Year 2025
During a recent inquiry requested by the Committee on House Administration (CHA), the Office of Inspector General (OIG) identified issues which we believe warrant the attention of the United States Capitol Police (USCP or Department) leadership. A Standard Operating Procedure (SOP) within the Protective Services Bureau (PSB), Investigations Division (ID) includes contradictory statements regarding required training for Special Agents. Further, the Department does not have established guidance to (1) address when it is appropriate for a Protective Services Officer (PSO) in Training to attend field interviews or (2) set requirements for the use of audio recording devices when conducting interviews.